Dr. Andrew Pasternak (Ph.D., MBA) has been directing research and commercialization of technologies for over 16 years across a number industry sectors, including chemical, medical devices, drug discovery, pharmaceutical services, and instrumentation. He has extensive experience in technology evaluation, managing multi-disciplined technical teams to develop market ready products, and implementing effective business development and marketing strategies.
Dr. Pasternak held several positions directing research and operations in the chemical and biotechnology sectors. He was Director of Research at Covalon Technologies Ltd., Director of Drug Discovery & Lead Optimization at Transition Therapeutics Inc., Sr. Director at MDS Protana, General Manager of Optimol Inc., Director of Science & Technology at MDS Proteomics, and Manager of New Technologies at MDS Sciex. He is currently Commercial Director for GreenCentre Canada, managing the development and commercialization of a broad portfolio of chemical technologies.
Dr. Pasternak has a Ph.D. and M.S. (Northwestern University) and B.S.E (University of Michigan) in bio-chemical engineering. He also has an MBA from the Rotman School of Business (University of Toronto), focusing on finance and strategy.